Skip to main content
logo
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

SONN Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Market Capitalization
94573535
Market Cap Growth
242.32%-13.25%-30.09%-79.64%0.50%-
Enterprise Value
81-222932
Last Close Price
1.266.6922.92258.721493.186332.48

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
PS Ratio
3.41233.5833.9320.5072.86-
PB Ratio
--8.96-22.19-2.831.5811.61
P/TBV Ratio
----1.5811.61

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
EV/Sales Ratio
8.3550.81-6.3560.68-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Debt / Equity Ratio
-0.02-0.27-0.90-0.100.010.12
Asset Turnover
0.260.010.030.020.03-
Quick Ratio
0.180.280.550.464.121.56
Current Ratio
0.260.660.860.664.301.62
Return on Equity (ROE)
----301.42%-197.66%-27822.18%
Return on Assets (ROA)
-223.80%-180.62%-208.63%-106.50%-84.78%-270.89%
Return on Invested Capital (ROIC)
----184.48%-121.74%-2921.10%
Return on Capital Employed (ROCE)
461.50%2698.20%19757.40%1270.70%-112.50%-532.50%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Earnings Yield
-157.59%-170.95%-375.53%-414.34%-70.90%-69.20%
FCF Yield
-119.86%-197.85%-425.56%-387.18%-64.01%-44.75%
Buyback Yield / Dilution
-469.85%-404.96%-425.71%---
SEC Filings: 10-K · 10-Q